Fig. 5: Glioblastoma tumor growth and molecular profiles in response to YY1 and miR-605-3p modulation.
From: Deciphering the YY1/ lncRNA BLACAT1/miR-605-3p axis in glioblastoma: implications for therapy
A Tumor tissue sizes of each group. B HE staining showing tissue components, with acidophilic structures stained in pink and alkaline structures stained in blue-purple or purple-red. C RT-qPCR results indicating transcription level changes in YY1, lncRNA BLACAT1, miR-605-3p, and downstream genes in xenograft tumor tissues. D Western blot analyses depicting protein expression levels of target genes in different xenograft groups. ns p > 0.05, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Each experiment was performed with three independent biological replicates.
